SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001367644-17-000034
Filing Date
2017-08-04
Accepted
2017-08-03 17:46:51
Documents
52
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 form10-q063016.htm 10-Q 952735
2 ex12.htm EX-12 54909
3 exhibit31_1.htm EX-31 12934
4 exhibit31_2.htm EX-31 12931
5 exhibit32_1.htm EX-32 3369
6 exhibit32_2.htm EX-32 3318
  Complete submission text file 0001367644-17-000034.txt   4289104

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT ebs-20170630.xml EX-101.INS 600023
8 XBRL TAXONOMY EXTENSION SCHEMA ebs-20170630.xsd EX-101.SCH 39145
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ebs-20170630_cal.xml EX-101.CAL 82550
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ebs-20170630_def.xml EX-101.DEF 179676
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE ebs-20170630_lab.xml EX-101.LAB 617355
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ebs-20170630_pre.xml EX-101.PRE 333569
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Filer) CIK: 0001367644 (see all company filings)

IRS No.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33137 | Film No.: 171006272
SIC: 2834 Pharmaceutical Preparations